Dependence MCQs With Answer for B.Pharm students: Understanding drug dependence—its pharmacology, mechanisms, clinical features, and management—is essential for safe therapeutics. This set of focused, evidence-based MCQs covers physical and psychological dependence, tolerance, withdrawal syndromes, receptor adaptations (GABA, NMDA, mu-opioid, nicotinic), diagnostic frameworks, scoring tools (CIWA-Ar, COWS), and pharmacotherapies (methadone, buprenorphine, naloxone, naltrexone, disulfiram, acamprosate, varenicline, bupropion). Questions emphasize pharmaco-therapeutic principles, detox strategies, harm reduction, drug interactions and factors influencing abuse potential. Designed to deepen your clinical reasoning, these practice questions help B.Pharm students prepare for exams and patient-care decisions. Now let’s test your knowledge with 30 MCQs on this topic.
Q1. Which statement best defines physical dependence?
- Physiological adaptation producing withdrawal symptoms on abrupt cessation
- Compulsive drug-seeking despite harm
- Legal requirement for prescription monitoring
- Increased pleasure from repeated drug use
Correct Answer: Physiological adaptation producing withdrawal symptoms on abrupt cessation
Q2. Psychological dependence is primarily characterized by which feature?
- Development of life-threatening withdrawal symptoms
- Compulsive craving and drug-seeking behavior
- Immediate organ toxicity from the drug
- Only pharmacokinetic tolerance
Correct Answer: Compulsive craving and drug-seeking behavior
Q3. What does pharmacological tolerance refer to?
- Reduced drug effect after repeated administration requiring higher doses
- Development of withdrawal symptoms on cessation
- Increased adverse effects with continued use
- Permanent immunity to drug actions
Correct Answer: Reduced drug effect after repeated administration requiring higher doses
Q4. Which cellular mechanism commonly contributes to opioid tolerance?
- Mu-opioid receptor desensitization and downregulation
- Upregulation of dopamine D2 receptors
- Inhibition of CYP3A4 metabolism
- Increased renal clearance of opioids
Correct Answer: Mu-opioid receptor desensitization and downregulation
Q5. Typical features of opioid withdrawal include:
- Lacrimation, yawning, piloerection, mydriasis and rhinorrhea
- Grand mal seizures and hyperthermia
- Profound euphoria and hyperphagia
- Severe hallucinations and visual disturbances
Correct Answer: Lacrimation, yawning, piloerection, mydriasis and rhinorrhea
Q6. Which complication of alcohol withdrawal is life-threatening and requires urgent management?
- Delirium tremens
- Mild tremor and insomnia
- Increased appetite
- Pinpoint pupils
Correct Answer: Delirium tremens
Q7. First-line pharmacotherapy for severe alcohol withdrawal is:
- Benzodiazepines
- Naltrexone
- Disulfiram
- Acamprosate
Correct Answer: Benzodiazepines
Q8. Which medication is commonly used for opioid maintenance therapy in dependence treatment?
- Methadone
- Flumazenil
- Disulfiram
- Acamprosate
Correct Answer: Methadone
Q9. Which agent is a partial opioid agonist used to treat opioid dependence?
- Buprenorphine
- Naloxone
- Morphine
- Naltrexone
Correct Answer: Buprenorphine
Q10. Which drug is the opioid antagonist of choice for reversing acute opioid overdose?
- Naloxone
- Naltrexone
- Methadone
- Buprenorphine
Correct Answer: Naloxone
Q11. Naltrexone is primarily used in dependence management for which purpose?
- Maintenance therapy to prevent relapse
- Immediate reversal of opioid overdose
- Alleviating acute benzodiazepine withdrawal
- Enhancing alcohol metabolism via ADH induction
Correct Answer: Maintenance therapy to prevent relapse
Q12. Disulfiram reduces alcohol consumption by which mechanism?
- Inhibition of aldehyde dehydrogenase leading to acetaldehyde accumulation
- Blocking histamine H1 receptors causing aversion
- Enhancing GABAergic transmission to reduce craving
- Competitive antagonism at NMDA receptors
Correct Answer: Inhibition of aldehyde dehydrogenase leading to acetaldehyde accumulation
Q13. Acamprosate helps maintain abstinence in alcohol dependence primarily by:
- Modulating glutamatergic neurotransmission and restoring GABA-glutamate balance
- Inhibiting aldehyde dehydrogenase
- Acting as a mu-opioid receptor agonist
- Directly blocking dopamine reuptake
Correct Answer: Modulating glutamatergic neurotransmission and restoring GABA-glutamate balance
Q14. The CIWA-Ar scale is used to:
- Assess severity of alcohol withdrawal
- Detect opioid intoxication
- Measure nicotine dependence
- Assess benzodiazepine blood levels
Correct Answer: Assess severity of alcohol withdrawal
Q15. The COWS score is a clinical tool for assessing:
- Opiate withdrawal severity
- Alcohol withdrawal severity
- Benzodiazepine intoxication
- Nicotine withdrawal symptoms
Correct Answer: Opiate withdrawal severity
Q16. Which pair demonstrates cross-tolerance due to similar CNS depressant actions?
- Benzodiazepines and alcohol
- Methadone and naloxone
- Nicotine and bupropion
- Disulfiram and acamprosate
Correct Answer: Benzodiazepines and alcohol
Q17. Chronic benzodiazepine use leads to dependence mainly through:
- GABA-A receptor downregulation and neuroadaptation
- Increased monoamine oxidase activity
- Permanent increase in glutamate synthesis
- CYP2D6 induction causing faster metabolism
Correct Answer: GABA-A receptor downregulation and neuroadaptation
Q18. Which drug is used as a specific antagonist in benzodiazepine overdose?
- Flumazenil
- Naloxone
- Activated charcoal
- Naltrexone
Correct Answer: Flumazenil
Q19. First-line pharmacotherapy options to aid smoking cessation include:
- Nicotine replacement therapy (NRT)
- Disulfiram
- Methadone maintenance
- Flumazenil infusion
Correct Answer: Nicotine replacement therapy (NRT)
Q20. Varenicline aids smoking cessation by acting as a:
- Partial agonist at α4β2 nicotinic acetylcholine receptors
- Full agonist at mu-opioid receptors
- Monoamine oxidase inhibitor
- GABA-B receptor antagonist
Correct Answer: Partial agonist at α4β2 nicotinic acetylcholine receptors
Q21. Bupropion assists in nicotine dependence through its primary mechanism as:
- A norepinephrine-dopamine reuptake inhibitor
- An aldehyde dehydrogenase inhibitor
- A benzodiazepine receptor agonist
- An NMDA receptor antagonist
Correct Answer: A norepinephrine-dopamine reuptake inhibitor
Q22. Which pharmacokinetic property increases a drug’s abuse and dependence potential?
- Rapid onset of central effects
- Very slow oral absorption
- Extensive first-pass metabolism reducing bioavailability
- Long elimination half-life with steady plasma levels
Correct Answer: Rapid onset of central effects
Q23. Which change did DSM-5 introduce regarding the terminology for drug problems?
- Replaced “dependence” with “substance use disorder” spectrum
- Eliminated the concept of withdrawal entirely
- Defined dependence as always synonymous with tolerance
- Classified addiction as a personality disorder
Correct Answer: Replaced “dependence” with “substance use disorder” spectrum
Q24. Which statement correctly contrasts tolerance and dependence?
- Tolerance is reduced effect to a drug; dependence is manifested by withdrawal on cessation
- Tolerance always causes withdrawal symptoms
- Dependence is exclusively psychological without physical signs
- Tolerance is permanent after short-term use
Correct Answer: Tolerance is reduced effect to a drug; dependence is manifested by withdrawal on cessation
Q25. Withdrawal from which class is most associated with risk of seizures and delirium if unmanaged?
- Benzodiazepines and alcohol
- Narcotic analgesics
- Nicotine replacement therapies
- SSRIs
Correct Answer: Benzodiazepines and alcohol
Q26. The therapeutic use of methadone to suppress heroin withdrawal while preventing cravings is an example of:
- Cross-dependence
- Pharmacokinetic enhancement
- Antagonistic overdose treatment
- Behavioral aversion therapy
Correct Answer: Cross-dependence
Q27. Which pharmacokinetic factor lowers withdrawal severity and dependence risk?
- Long elimination half-life producing smoother plasma levels
- Rapid intravenous bolus administration
- High lipophilicity with swift brain penetration
- Short half-life requiring frequent dosing
Correct Answer: Long elimination half-life producing smoother plasma levels
Q28. Office-based management of opioid use disorder commonly uses which medication for outpatient induction and maintenance?
- Buprenorphine
- Flumazenil
- Acamprosate
- Naloxone infusion
Correct Answer: Buprenorphine
Q29. The mesolimbic reward pathway primarily involves increased release of which neurotransmitter in the nucleus accumbens?
- Dopamine
- GABA
- Acetylcholine
- Glutamate
Correct Answer: Dopamine
Q30. Which harm-reduction strategy is evidence-based for reducing infectious disease transmission among people who inject drugs?
- Needle and syringe exchange programs
- Mandatory inpatient detoxification only
- Complete prohibition of opioid substitution therapy
- Providing flumazenil in community centers
Correct Answer: Needle and syringe exchange programs
